Aim. Runx2 (AML3) transcription factor is the key regulator of osteoblastic lineage progression and is indispensable for the formation of mineral bones. Runx2 expression increases during differentiation of
Introduction. Bone development, repair and remodeling homeostasis require constant differentiation of mesenchymal stem cells through osteoprogenitors to mature osteoblasts and osteocytes. Consistent with the recent discoveries that a cell fate can be programmed by only few master transcriptional regulators, the cell fate along osteoblastic lineage is regulated by Runx2 and Osterix factors, both indispensable for bone formation [1, 2] .
Runx2 factor regulates expression of multiple target genes via direct activation and repression of genes transcription or by epigenetic remodeling of gene regulatory sequences [3] .
Multiple Runx2 target genes are responsible for bone mineral production at the late stages of osteoblasts maturation. However, Runx2 expression starts very early along osteoblastic lineage, and its role at the early steps of osteogenic commitment is scarcely understood. This research is focused on the fundamental mechanisms of osteoprogenitors programming by Runx2. We have compared the transcriptomes of Runx2 null osteoprogenitor cells before and after their reconstitution with wild type Runx2 protein or its non-functional mutant using Affymetrix microarrays. We have found that several clusters of functionally related genes respond to Runx2 re-introduction. They include the genes related to the osteoblast-specific signaling network, hormones biosynthesis and general metabolism. These genes define osteoblast cell identity in the bone microenvironment.
Materials and methods. Cell culture and adenovirus infections. Runx2 null calvaria osteoprogenitors cell line was developed previously from the fetal calvarial region of Runx2 knock-out mice by stable integration of Tert [4] . Runx2 null cells were maintained in aMEM supplemented with 10 % fetal bovine serum (FBS) («Atlanta Biologicals», USA), 30 mM penicillin-streptîmycin and 100 mM L-glutamine at 37 °C and 5 % CO 2 humidified atmosphere. Adenoviral vectors containing cDNAs of full length Runx2 and its Cterminal deletion mutants were each transferred into the AdenoVator TM expression construct («Qbiogene», USA) from the corresponding pcDNA expression vectors described previously.
Cells were plated for infections in 6-well plates (12.5×10 4 cells/well). After 24 h, cells were infected with 100 MOI of each virus in 600 ml of aMEM media complemented with 1 % FBS for 4 h. Upon addition of 400 ml media containing 1 % FBS, cells were incubated for additional 10 h.
Affymetrix analysis. Total RNA for Affymetrix analysis (and subsequent qRT-PCR validation) was isolated with Trizol reagent and purified using the RNeasy Mini Kit («Qiagen», USA). Analysis of gene expression using Mouse Genome 430 2.0 Array was performed as described earlier [5] . Data processing and sample comparisons were performed using an open source library for statistical analysis (BioConductor library for R environment; http://www.bioconductor. org). Following Robust Multi-array Average expression measurement (RMA) and background correction, the array values were subjected to quantile normalization assuming identical signal distributions in each of the arrays. Statistically significant differences between probe sets were evaluated using Student's T test (p < < 0.05). Functional annotation of Affymetrix probe sets and gene ontology relationships between groups of coregulated genes were assessed using the Database for Annotation, Visualization and Integrated Discovery (DAVID 2.0) (http://david.abcc.ncifcrf.gov) [6] .
Western blot analysis. Cell lysates were prepared from cell pellets that were boiled in 100 ml of Direct Lysis buffer (50 mM Tris-HCl, pH 6.8, 2 % SDS, 10 % Glycerol, 12 % Urea, 25 mM MG132, 100 mM DTT and 1 ´ Complete protease inhibitors) («Roche», USA). Aliquots of each lysate (5 ml) were separated in 10 % sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). Proteins were transferred using semi-wet blotting to nitrocellulose membranes («Millipore», USA). Phosphatase buffered saline (PBS) with 5 % non-fat milk was used for 1 h at room temperature to block non-specific protein binding. Primary and secondary antibodies were used at 1:2,000 dilutions for 1 h room temperature in PBS/0.1 % Tween (PBST) with 1 % milk. Signal was detected with ECL (Perkin Elmer Western Lighting Chemiluminescence Reagent Plus, «Perkin Elmer», USA). RUNX2-specific mouse monoclonal antibodies were a generous gift of Dr. Yoshiaki Ito (Institute for Molecular and Cellular Biology, Singapore). CDK2 rabbit polyclonal antibodies (SC-163) were purchased from Santa Cruz Biotechnology, Santa Cruz, USA.
Quantitative real-time reverse transcriptase PCR (qRT-PCR) analysis. qRT-PCR was performed to validate changes for the sub-set of Runx2 responsive genes. Specific qPCR primers were designed using Primer 3 software. Total RNA for qRT-PCR assays was isolated as described, subjected to DNaseI digestion and purified using an RNA purification kit («Zy-mogen», USA). Aliquots of RNA (1 mg) were used for reverse transcription (First strand cDNA synthesis kit, «Invitrogen», USA) with random hexamer primers. Quantitative PCR was performed with Power SYBR Green PCR Master Mix («Applied Biosystems», USA) using an automated system (Applied Biosystems 7300 Real Time PCR System) with 0.5 pmoles/ml of the specific gene primers.
Results and discussion. Functional clustering of Runx2 responsive genes in osteoprogenitors. To investigate Runx2 involvement in the programming of osteoprogenitors, we used the model system of early mouse calvaria osteoprogenitors with Runx2 null background. These cells are blocked at the very early stage of osteogenic lineage because of the absence of Runx2 gene; although they deposit collagen into extracellular matrix, they do not express other phenotypic mar-kers and are not able to differentiate and mineralize in osteogenic media (ascorbic acid and beta-glycerophosphate). After cells reconstitution with exogenously expressed Runx2 protein the block is released and cells progress along osteoblatic lineage, differentiate to normal osteoblasts and mineralize in osteogenic media.
To assess the global changes in gene expression during the osteoblatic lineage the genome-wide Affymetrix expression profiling was performed with the investigated cells reconstituted with either wild type (WT) Runx2 protein or with its C-terminally truncated deletion mutant (Runx2-DC), which is non-functional because of the absence of transactivation and repression domains (Fig. 1) .
Data analysis after Runx2 WT and Runx2-DC introduction revealed total 1828 probe-sets and 1438 up-and down-regulated genes (with more than 1.4 fold changes, p < 0.05) ( Table) . Functional clustering of these genes has shown that several clusters of functionally related genes are responsive to Runx2 introduction, and include the genes related to cell signaling pathways, general metabolism, transport, cell cycle and osteoblast phenotype. The changes in expression of selected subset of 180 genes were validated by quantitative PCR (qPCR) analysis and revealed a significant consistency with the data obtained by microarray.
Early osteoblast phenotypic genes are induced by Runx2 in osteoblasts progenitors. As we expected, the functional clustering of results has shown that the genes of the early/middle osteoblast differentiation encoding Osteocalcin, Osteopontin, some collagens and Matrix metalloproteinases, were robustly induced by Runx2 within 1 day after Runx2 re-introduction (Fig. 2) . The genes characteristic for the late differentiation stage encoding Bone sialoprotein, Alkaline phosphatase have not revealed detectable expression (data not shown).
Matrix metalloproteinases Mmp9, Mmp13 and some other collagen matrix processing enzymes (i. e. Loxl2, Loxl3, Tissue Inhibitors of Matrix Metalloproteinases Timp1 and Timp3) were robustly induced by Runx2, while others (i. e. Timp2) were inhibited. Consistently, a sub-set of bone-related Runx2 responsive genes like secreted phosphoprotein (Spp1, Osteopontin), Bone gamma-carboxyglutamate (Bglap1, Osteocalcin) were also up-regulated. Some genes in the list encode other master fate-determining transcription factor in osteoblasts acting up-and downstream of Runx2 protein (e. g. Core binding factor beta (Cbfb), Sp7 or Osterix).
Runx2 programs bone-related signaling network in osteoprogenitor cell. Along with the cluster of osteo- blast phenotypic gene markers, several other big clusters of interrelated genes were responsive to Runx2. The biggest of these clusters includes genes coding for cell signaling pathways, namely transmembrane receptors, extra-and intracellular modulators of their activity, cytoplasmic secondary messengers and the nuclear effectors. Among the most affected signaling pathways we identified all known critical signaling components in osteogenesis, including FGF, BMP/TGFbeta, Wnt and small G-proteins coupled signaling (e. g. PTH/ PTHrP, non-genomic steroid receptor Gpr30, cAMP signaling, growth factors FGF and EGF signaling).
We further arranged a sub-cluster of Runx2 responsive genes related to G-protein coupled signaling in osteoblasts (Fig. 3) . A bunch of G-protein coupled receptors and their interacting G-proteins are up-and down-regulated in osteoprogenitors. Some of these genes are known to play a role in osteoblastic cells (e. g. non-genomic Estrogen receptor Gpr30, Gper), while the function of other G-proteins coupled receptors (e. g. Gpr54, Gpr23) in bone has to be determined. The four of the Small Regulators of G-proteins (Rgss) are repressed by Runx2: Rgs2, 4, 5 and 16 (Fig. 3) . Notably, Rgs2 and Rgs4 are known as molecular switches directing the signal along different ways from PTH/ PTHrP receptor [7, 8] , the critical modulator of osteoblastic differentiation, growth and function [9] . Further investigation is needed to determine if these changes affect signaling pathway from PTH/PTHrP receptor during differentiation.
The second sub-cluster includes the extracellular matrix/proteoglycan genes known as the regulators of 276 TEPLYUK N. M., TEPLYUK V. I.
Functional cluster
Probe-sets The number of genes up-and down-regulated by Runx2 in osteoprogenitors FGF, Wnt and BMP signaling, critical in the bone cells [10, 11] . Heparane sulfate proteoglycanes (Syndecanes) physically interact with FGF receptors as well as FGF ligands and regulate signaling activity depending on the types of Heparane sulfate chains present [12] . The enzymes modifying chemical composition of Heparane sulfate chains components along with Proteoglycans co-repressors themselves are Runx2 responsive (Fig. 4) , indicating that Runx2 plays a role as a modulator of the whole FGF signaling system. Runx2 modulates steroid hormones biosynthesis and cholesterol metabolism machinery in osteoprogenitors. The second big cluster of genes responsive to Runx2 includes the genes responsible for cellular metabolism (Table) , particularly for lipid/fatty acid, sugars and energy metabolism, red-ox homeostasis and cholesterol/steroid hormones biogenesis (Fig. 5 ). There are genes coding for the enzymes for several consecutive steps of cholesterol biosynthesis (Fdps, Lss, Cyp51, Dhcr) following by Cholesterol downstream conversion to Pregnenolone (Cyp11a1, Fdxr) are induced by Runx2. Interestingly, the genes related to bonecatabolic glucocorticoids signaling, including Glucocorticoid receptors (Nr3c1, Nr2c2) and Glucocorticoid-induced gene (Gig1, Zfp704) are inhibited by Runx2 expression (Fig. 5) . Taken together these data suggest that Runx2 may promote the endogenous biogenesis of some anabolic steroid hormones derivatives of cholesterol in differentiating osteoblasts, while repressing signaling from catabolic glucocorticoids.
We performed genome-wide screening of the genes that are directly or indirectly regulated by the bone master regulatory transcription factor Runx2 at the early stage of osteoblastic commitment. We found that several interrelated functional gene programs are architected by the presence of Runx2 in osteoprogenitors, including early steps of bone matrix production, regulation of osteoblastic cell cycle, general metabolism, steroids biogenesis and the membrane/intracellular signaling network.
Genetic alterations of osteoblast specific signaling pathways that we have identified -FGF, PTH/PTHrP, BMP, TGFb and Wnt signaling, cause hereditary syndromes with prominent bone abnormalities. Also, there are tremendous amount of accumulated evidences that each of above-mentioned signaling pathways plays a critical role in osteoblasts development and bone formation, both in vivo and in vitro [13] .
Moreover, proper hormone signaling involving all classes of steroids is critical for bone development and homeostasis. For example deficiency of Estrogen or Androgen receptor leads to severe osteoporosis; deficiency of Vitamin D is well known to cause Rickets, while glucocorticoid treatment is associated with glucocorticoid-induced osteoporosis.
Taken together, these results guided us to a novel fundamental concept that the master transcriptional regulator (i. e. Runx2) changes representation of the total signaling network of the cell, and that such change may be a principal part of the fate-determining program to define cell identity in the environment. In other words, due to reprogramming its signaling network, Runx2 expressing osteoprogenitor reacts and behaves differently from its mother Mesenchymal stem cell in the same bone microenvironment, retaining the osteoprogenitor identity memory. The retention of such memory can be realized by chromatin remodeling (as Runx2 is a part of chromatin modification complexes) as well as by the retention of Runx2 on mitotic chromosomes through progenitor cells generations.
At the same time, using bone as a model system, it is a part of broader biological problem of understanding the complete mechanism of cell specialization and (re)programming by master regulatory factors. Still far from understanding, this question is of the critical importance in the new and fast growing field of stem cell-based regenerative medicine, which has tremendous potential for improving both healthcare and human wellbeing.
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Òðà íñêðèï öè îí íûé ôàê òîð Runx2 ðå ãó ëè ðó åò ãå íå òè ÷åñ êèå ïðî ãðàì ìû, ñâÿ çàí íûå ñ ñèã íà ëèí ãîì è ìå òà áî ëèç ìîì ïðåä øåñ òâåí íè êîâ îñòå îá ëàñòîâ Ðå çþ ìå Cytochrom P450, family 1, subfamily b, polypeptide 1 Nr3c1
Öåëü. Òðà íñêðèï öè îí íûé ôàê òîð Runx2 (AML3) ÿâ ëÿ åò ñÿ êëþ -÷å âûì ðå ãó ëÿ òî ðîì äèô ôå ðåí öè à öèè îñòå îá ëàñ òîâ, íå îá õî äè -ìûì äëÿ ôîð ìè ðî âà íèÿ êîñ òåé. Ýêñïðå ñèÿ ãåíà Runx2 ïîâû-øà åò ñÿ â ïðî öåñ ñå äèô ôå ðåí öè à öèè îñòå îá ëàñ òîâ, ãäå îí àê -òè âè ðó åò îñòå îá ëàñò-ñïå öè ôè ÷åñ êèå ãåíû, íå îá õî äè ìûå äëÿ ïðîäóê öèè ìè íå ðàëü íî ãî ìàò ðèê ñà. Öåëü ðà áî òû ñî ñòî ÿ ëà â îïðå äå ëå íèè ôóíê öèè ãåíà
Nuclear receptor subfamily 3, group C, member 1 Nr3c2
Nuclear receptor subfamily 3, group C, member 2 Nr3c1
Nuclear receptor subfamily 3, group C, member 1 Fig . 5 . Runx2-responsive genes related to steroid hormones signaling and metabolism in osteoprogenitors
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